APIM Therapeutics Competitors and Similar CompaniesClear all
APIM Therapeutics's competitors and similar companies include Imugene.
 APIM Therapeutics APIM Therapeutics is a clinical-stage biotech company focusing on the development of treatments in the fields of oncology and inflammation. | ||
Founding Date | Founding Date 2010 | Founding Date 2013 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Trondheim, NO HQ Rissa, NO | Locations SYDNEY, AU HQ |
Employees | Employees 7 | Employees N/A |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods kr1.2m (FY, 2021) | Cost of goods N/A |
Gross profit | Gross profit (kr1.2m) (FY, 2021) | Gross profit $4.4m (FY, 2025) |
Net income | Net income (kr14.8m) (FY, 2021) | Net income ($69m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Imugene
HQ
SYDNEY, AU
Imugene is a clinical-stage immuno-oncology company developing cancer treatments.
View company